
Prostate cancers that are resistant to androgen deprivation therapy are more invasive and are more likely to spread to other organs than are androgen-dependent prostate cancers, according to UCLA researchers. The findings could change the way some prostate cancers are treated, spurring earlier use of hormone therapy to prevent the cancer’s spread, said senior author Robert Reiter, MD.